LONE TREE, Colo., Jan. 8, 2026 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, is proud to announce that the groundbreaking Nucleus® Nexa® System is now available to ...

LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...

The new Cochlear™ Nucleus® Nexa® System is the first and only hearing implant featuring internal memory and upgradeable firmware. Approximately 63 million people in India suffer from significant ...

Hearing is one of those things most people never think about until it’s gone. For millions living with severe to profound hearing loss, a cochlear implant isn’t just a device. It’s a way back to ...

The Cochlear Ltd (ASX: COH) share price is in focus today after the hearing implant leader posted a modest 1% lift in sales revenue to $1,176 million for the half year ended December 2025, but ...

Cochlear's interim 2026 underlying net profit after tax was down 10%. Sales fell 2% due to contracting delays for the new Nucleus Nexa implant in developed markets. Inefficient manufacturing and ...

For more than three decades, Lisa Aubert has helped transform both hearing technology and the lives of the people who depend on it. She began her career at Cochlear in 1994 as an audiologist in Europe ...

Cochlear Ltd (ASX:COH) presented its half-year 2026 results on February 13, revealing mixed financial performance that triggered a significant market reaction. The global hearing implant leader ...